EBCC 2024 | Drivers of surgical choice in breast cancer following neoadjuvant therapy

Federica Martorana, MD, University of Catania, Catania, Italy, discusses findings from a retrospective analysis from the EUSOMA database of factors that influence whether patients with breast cancer receive breast-conserving surgery or mastectomy following neoadjuvant therapy. Age, multifocal disease, and tumor size all affected the choice of surgery. Baseline tumor extension and the COVID-19 pandemic may also have an effect on surgery choice. This interview took place at the 14th European Breast Cancer Conference (EBCC) in Milan, Italy.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.